Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|December 19, 2009
Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platformTristan M Sissung, Bevin C English, David Venzon, et al.
Genes & Diseases|March 26, 2019
Endosomal trafficking defects in patient cells with KIAA1109 biallelic variantsMegan S Kane, Callie J Diamonstein, Natalie Hauser, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2015
Preclinical assessment of the interactions between the antiretroviral drugs, ritonavir and efavirenz, and the tyrosine kinase inhibitor erlotinibJohn F Deeken, Jan H Beumer, Nicole M Anders, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2014
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposureMichelle A Rudek, Cathy Y Chang, Kenneth Steadman, et al.
Molecular and Cellular Biochemistry|November 13, 2008
The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variantOrsolya Polgar, John F Deeken, Lilangi S Ediriwickrema, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2012
The rising challenge of non-AIDS-defining cancers in HIV-infected patientsJohn F Deeken, Angelique Tjen-A-Looi, Michelle A Rudek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2010
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, et al.
Childhood Obesity (Print)|October 10, 2019
Association of Ancestral Genetic Admixture and Excess Weight at Twelve Months of AgeSahel Hazrati, Kathi Huddleston, Sara Sadat-Hossieny, et al.
Pediatric Research|January 16, 2019
Clinical and social factors associated with excess weight in Hispanic and non-Hispanic White childrenSahel Hazrati, Farah Khan, Kathi Huddleston, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2014
A phase I study of oral ixabepilone in patients with advanced solid tumorsJohn F Deeken, John L Marshall, Michael J Pishvaian, et al.
Pageof 4